Dexcom (DXCM)

Cost of Revenue

$1.86B

TTM · Period ending: · USD

DXCM logo

DXCM Cost of Revenue

Latest reported$1.86B
DXCM TTM Cost of Revenue ($0.00 → $1.86B)
High-resolution chart · PNG

DXCM cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Dexcom Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
1,864,800,000
1,854,700,000
1,860,100,000
1,850,900,000
1,773,400,000
1,682,700,000
1,594,800,000
1,515,000,000
1,466,300,000
1,413,600,000
1,333,400,000
1,229,400,000
1,153,100,000
1,074,900,000
1,026,700,000
978,400,000
906,300,000
837,600,000
768,000,000
712,200,000
669,400,000
659,100,000
646,600,000
630,300,000
619,200,000
581,400,000
544,500,000
506,200,000
454,900,000
413,900,000
367,700,000
320,000,000
279,500,000
243,700,000
226,400,000
213,400,000
203,300,000
202,000,000
194,900,000
180,000,000
163,000,000
138,400,000
123,600,000
108,900,000
100,200,000
91,900,000
82,900,000
75,600,000
69,100,000
64,100,000
59,900,000
57,998,000
57,385,000
55,692,000
53,300,000
49,330,000
44,733,000
42,072,000
40,422,000
37,341,000
35,439,000
33,160,000
30,188,000
27,905,000
26,111,000
26,643,000
26,032,000
24,559,000
22,005,000
17,599,000
15,366,000
14,130,000
13,403,000
12,916,000
12,736,000
12,479,514
12,755,189
11,939,733
10,958,953
7,560,439
4,171,764
2,081,220
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.